Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models.
Tumor-associated macrophages (TAMs) drive the immunosuppressive tumor microenvironment (TME), promoting oncogenic progression, metastasis and treatment resistance. While we previously established that intratumoral administration of poly(I:C) and R848 (TLR3 and TLR7/8 agonists) has strong therapeutic efficacy and trigge...